The pharma lab in times of cell & gen...After two years online, PharmaLab 2022 returns on site for its 10th edition. Over three days, the congress will offer the opportunity to share the latest experiences with colleagues and to exchange … more ➔
A spotlight on tomorrow’s CROThe CRO industry is predicted to grow considerably over the next five years. Trials are becoming more complex, and technology is becoming increasingly interwoven with processes. The CRO of tomorrow must … more ➔
Knowledge-based contract servicesTo install a newly created Chief Scientific Officer position and to hire a biotech veteran is a signal sent by Rentschler Biopharma, celebrating 150 years. more ➔
Bringing virotherapy forwardWhether it´s oncolytic viruses or vectors for cancer therapy or modern vaccines, the demand for development, production or filling capacities is rising rapidly. To keep pace with this rise in customer … more ➔
The BIOTECH Insight Newsletter presents ne...In the present newsletter special issues will be reinforced and personality of branches interviewed. Financing in sustainable production (#BRAIN_AG), synBio and AI (AIgnostics) are highlights in the … more ➔
Non-viral is betterImmunogenicity and limited gene transfer capacity can negatively affect the outcome of cell and gene therapies. European Biotechnology magazine spoke to Dr Dimitrios Laurin Wagner, Berlin Center for … more ➔
Transformative innovation in drug developm...The technological and pharmacological advances lead to an increase in the number of molecules for R&D that are challenging and difficult to manufacture. To improve clinical success, pharma and … more ➔
Worldview national ranking of health biote... A current Nature study specifies the most competitive health biotech sectors worldwide and puts Switzerland at the top, Sweden second and the USA third. Does the new math convince? more ➔
Vetter wins at the 2022 CMO Leadership Awa...Vetter, a globally operating CDMO, won the 2022 CMO Leadership Awards in all six core categories – quality, expertise, compatibility, capabilities, reliability and service. Vetter also achieved Champion … more ➔
Lead optimisation – the sequence is...The efficacy of therapeutic antibodies is defined by their primary amino acid sequence. After discovery, antibody candidates often profit from protein engineering and sequence optimisation. Different … more ➔
